MedPath

TATA MAIN HOSPITAL

🇮🇳India
Ownership
-
Established
1908-01-01
Employees
-
Market Cap
-
Website
http://www.tatamainhospital.com/

Clinical Trials

30

Active:0
Completed:10

Trial Phases

4 Phases

Phase 1:1
Phase 2:1
Phase 4:2
+1 more phases

Drug Approvals

0

Drug Approvals

No drug approvals found

This company may not have drug approvals in our database

Clinical Trials

Distribution across different clinical trial phases (17 trials with phase data)• Click on a phase to view related trials

Not Applicable
13 (76.5%)
Phase 4
2 (11.8%)
Phase 1
1 (5.9%)
Phase 2
1 (5.9%)

A Comparative Evaluation of Nottingham Hip Fracture Score (NHFS) and Acute Physiology and Chronic Health Evaluation (APACHE) II Score to Predict 30-day Mortality in Geriatric Patients Above 60 Years Undergoing Hip Fracture Surgery.

Completed
Conditions
Geriatric Hip Fracture
First Posted Date
2024-09-19
Last Posted Date
2024-09-19
Lead Sponsor
Tata Main Hospital
Target Recruit Count
182
Registration Number
NCT06598566
Locations
🇮🇳

Tata Main Hospital, Jamshedpur, Jharkhand, India

Comparative Analysis of Incidence of Newly Developed Postoperative Low Back Pain with Field Block Versus Without Field-block Before Spinal Anaesthesia for Patients Undergoing Caesarean Sections

Not Applicable
Completed
Conditions
Caesarean Section
First Posted Date
2024-09-19
Last Posted Date
2024-09-19
Lead Sponsor
Tata Main Hospital
Target Recruit Count
220
Registration Number
NCT06602505
Locations
🇮🇳

Tata Main Hospital, Jamshedpur, Jharkhand, India

Dose Responsive Study of Ringer's Lactate Solution in Prevention of Post-induction Hypotension

Not Applicable
Recruiting
Conditions
Post Induction Hypotension
First Posted Date
2023-06-29
Last Posted Date
2023-06-29
Lead Sponsor
Tata Main Hospital
Target Recruit Count
100
Registration Number
NCT05924230
Locations
🇮🇳

Abhishek Chatterjee, Jamshedpur, Jharkhand, India

Study to Find the Percentage of Cases Retaining COVID-19 IgG Antibodies 45-65 After They Have Tested Positive

Completed
Conditions
Covid19
First Posted Date
2020-10-28
Last Posted Date
2020-10-28
Lead Sponsor
Tata Main Hospital
Target Recruit Count
201
Registration Number
NCT04605952
Locations
🇮🇳

Dr.Deb Sanjay Nag, Jamshedpur, Jharkhand, India

Effect of Intraoperative Dexmedetomidine on Early Postoperative Cognitive Dysfunction

Phase 4
Completed
Conditions
Cognitive Dysfunction
Interventions
First Posted Date
2019-01-04
Last Posted Date
2020-04-13
Lead Sponsor
Tata Main Hospital
Target Recruit Count
120
Registration Number
NCT03793751
Locations
🇮🇳

Dr.Deb Sanjay Nag, Jamshedpur, Jharkhand, India

  • Prev
  • 1
  • 2
  • Next

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.